Paper23345950
Clinical outcomes and predictive factors in oral corticosteroid-refractory active ulcerative colitis.
Jeon HH and 9 others. World J Gastroenterol, 2013. Cited by 20 papers, by iCite.
Cite this record
ConductScience Library. Clinical outcomes and predictive factors in oral corticosteroid-refractory active ulcerative colitis. Papers, record 23345950. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23345950
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Clinical outcomes and predictive factors in oral corticosteroid-refractory active ulcerative colitis.
- PubMed
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adrenal Cortex Hormones | Major topic |
| Colitis, Ulcerative | Major topic |
| Drug Resistance | Major topic |
| Administration, Intravenous | |
| Administration, Oral | |
| Adolescent | |
| Adult | |
| Aged | |
| Dose-Response Relationship, Drug | |
| Female | |
| Follow-Up Studies | |
| Hemoglobins | |
| Humans | |
| Male | |
| Middle Aged | |
| Prognosis | |
| Retrospective Studies | |
| Time Factors | |
| Treatment Failure | |
| Treatment Outcome | |
| Young Adult |
Source PubMed
References39
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15449985 | Response of first attack of inflammatory bowel disease requiring hospital admission to steroid therapy. | Rev Esp Enferm Dig | 2004 | https://conductscience.org/library/papers/15449985 | PubMed |
| 2 | 20347730 | Nonelective excisional colorectal surgery in English National Health Service Trusts: a study of outcomes from Hospital Episode Statistics Data between 1996 and 2007. | J Am Coll Surg | 2010 | https://conductscience.org/library/papers/20347730 | PubMed |
| 3 | 7129207 | Plasma prednisolone levels during intravenous therapy in acute colitis. | Gut | 1982 | https://conductscience.org/library/papers/7129207 | PubMed |
| 4 | 20110709 | Do patients with ulcerative colitis diagnosed at a young age have more severe disease activity than patients diagnosed when older? | Digestion | 2010 | https://conductscience.org/library/papers/20110709 | PubMed |
| 5 | 15050885 | Prevalence and outcomes of anemia in inflammatory bowel disease: a systematic review of the literature. | Am J Med | 2004 | https://conductscience.org/library/papers/15050885 | PubMed |
| 6 | 6305758 | Corticotropin versus hydrocortisone in the intravenous treatment of ulcerative colitis. A prospective, randomized, double-blind clinical trial. | Gastroenterology | 1983 | https://conductscience.org/library/papers/6305758 | PubMed |
| 7 | 15142197 | Predicting the outcome of severe ulcerative colitis: development of a novel risk score to aid early selection of patients for second-line medical therapy or surgery. | Aliment Pharmacol Ther | 2004 | https://conductscience.org/library/papers/15142197 | PubMed |
| 9 | 12891531 | Corticosteroids and immunomodulators: postoperative infectious complication risk in inflammatory bowel disease patients. | Gastroenterology | 2003 | https://conductscience.org/library/papers/12891531 | PubMed |
| 10 | 15482530 | Severe ulcerative colitis: prospective study of parameters determining outcome. | J Gastroenterol Hepatol | 2004 | https://conductscience.org/library/papers/15482530 | PubMed |
| 11 | 3317057 | Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. | N Engl J Med | 1987 | https://conductscience.org/library/papers/3317057 | PubMed |
| 12 | 8882472 | Clinical features of ulcerative colitis in Korea. | Korean J Intern Med | 1996 | https://conductscience.org/library/papers/8882472 | PubMed |
| 13 | 17206722 | Clinical features and natural history of ulcerative colitis in Korea. | Inflamm Bowel Dis | 2007 | https://conductscience.org/library/papers/17206722 | PubMed |
| 14 | 10735919 | Predictive factors of outcome of intensive intravenous treatment for attacks of ulcerative colitis. | Aliment Pharmacol Ther | 2000 | https://conductscience.org/library/papers/10735919 | PubMed |
| 15 | 3031150 | Predicting the outcome of corticoid therapy for acute ulcerative colitis. Results of a prospective, randomized, double-blind clinical trial. | J Clin Gastroenterol | 1987 | https://conductscience.org/library/papers/3031150 | PubMed |
| 16 | 12452938 | Azathioprine without oral ciclosporin in the long-term maintenance of remission induced by intravenous ciclosporin in severe, steroid-refractory ulcerative colitis. | Aliment Pharmacol Ther | 2002 | https://conductscience.org/library/papers/12452938 | PubMed |
| 17 | 7364320 | Prednisolone absorption in acute colitis. | Gut | 1980 | https://conductscience.org/library/papers/7364320 | PubMed |
| 18 | 20479907 | Inflammatory bowel disease in Korea: epidemiological, genomic, clinical, and therapeutic characteristics. | Gut Liver | 2010 | https://conductscience.org/library/papers/20479907 | PubMed |
| 19 | 8503379 | Predictors and the rate of medical treatment failure in ulcerative colitis. | Am J Gastroenterol | 1993 | https://conductscience.org/library/papers/8503379 | PubMed |
| 20 | 11487534 | The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. | Gastroenterology | 2001 | https://conductscience.org/library/papers/11487534 | PubMed |
| 21 | 8984031 | Predicting outcome in severe ulcerative colitis. | Gut | 1996 | https://conductscience.org/library/papers/8984031 | PubMed |
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42318426 | Elevated TFR1 is associated with inflammatory burden and ferroptosis in ulcerative colitis. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42318426 | PubMed |
| 41766926 | Effectiveness of Intravenous Corticosteroid in Patients with Ulcerative Colitis after Oral Corticosteroid Failure: Differences by Prior Response to Oral Therapy in a Multicenter Cohort Study. | Inflamm Intest Dis | 2026 | https://conductscience.org/library/papers/41766926 | PubMed |
| 39264575 | Pharmacokinetics and Pharmacodynamics of Systemic Corticosteroids in Autoimmune and Inflammatory Diseases: A Review of Current Evidence. | Clin Pharmacokinet | 2024 | https://conductscience.org/library/papers/39264575 | PubMed |
| 38595816 | Decreasing the steroid rapidly may help to improve the clinical outcomes of patients with intestinal steroid-refractory acute graft-versus-host disease receiving basiliximab treatment. | Front Oncol | 2024 | https://conductscience.org/library/papers/38595816 | PubMed |
| 34425765 | Anti-proteinase 3 antineutrophil cytoplasmic antibody reflects disease activity and predicts the response to steroid therapy in ulcerative colitis. | BMC Gastroenterol | 2021 | https://conductscience.org/library/papers/34425765 | PubMed |
| 32352683 | The Long-Term Clinical and Endoscopic Outcomes of Cronkhite-Canada Syndrome. | Clin Transl Gastroenterol | 2020 | https://conductscience.org/library/papers/32352683 | PubMed |
| 31754992 | Corticosteroid Treatment at Diagnosis: An Analysis of Relapses, Disease Extension, and Colectomy Rate in Ulcerative Colitis. | Dig Dis Sci | 2020 | https://conductscience.org/library/papers/31754992 | PubMed |
| 30604378 | Serum Procalcitonin as a Potential Early Predictor of Short-Term Outcomes in Acute Severe Ulcerative Colitis. | Dig Dis Sci | 2019 | https://conductscience.org/library/papers/30604378 | PubMed |
| 28522918 | Combination of corticosteroids and 5-aminosalicylates or corticosteroids alone for patients with moderate-severe active ulcerative colitis: A global survey of physicians' practice. | World J Gastroenterol | 2017 | https://conductscience.org/library/papers/28522918 | PubMed |
| 28161855 | Short-Term Clinical Response to Corticosteroids Can Predict Long-Term Natural History of Ulcerative Colitis: Prospective Study Experience. | Dig Dis Sci | 2017 | https://conductscience.org/library/papers/28161855 | PubMed |
| 26131003 | Institutional Board Review for Clinical Investigations on Inflammatory Bowel Diseases: A Single-Center Study. | Intest Res | 2015 | https://conductscience.org/library/papers/26131003 | PubMed |
| 25780299 | Corticosteroid therapy in ulcerative colitis: Clinical response and predictors. | World J Gastroenterol | 2015 | https://conductscience.org/library/papers/25780299 | PubMed |
| 25691843 | Usefulness of the cytomegalovirus antigenemia assay in patients with ulcerative colitis. | Intest Res | 2015 | https://conductscience.org/library/papers/25691843 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23345950
GET https://conductscience.org/api/papers/v1/23345950/references?page=2